NEW YORK (GenomeWeb) – Cowen, Leerink, and JP Morgan have initiated coverage of immunoassay firm Quanterix.
Cowen and Leerink both gave the company an Outperform rating with the former giving no price target and the latter a price target of $27. JP Morgan initiated coverage with an Overweight rating and a price target of $24.